Phase I study of cis-diamminedicholoroplatinum [cisplatin] in combination with ICRF-187 [dexrazoxane] in the treatment of advanced malignancies.
Phase of Trial: Phase I
Latest Information Update: 28 Jul 2016
At a glance
- Drugs Dexrazoxane (Primary) ; Cisplatin
- Indications Solid tumours
- Focus Adverse reactions
- 15 Jan 2010 Actual end date (Jul 2007) added as reported by ClinicalTrials.gov.
- 15 Jan 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 15 Nov 2007 New trial record.